BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meng X, Song J, Lei Y, Zhang X, Chen Z, Lu Z, Zhang L, Wang Z. A metformin-based nanoreactor alleviates hypoxia and reduces ATP for cancer synergistic therapy. Biomater Sci 2021;9:7456-70. [PMID: 34609385 DOI: 10.1039/d1bm01303c] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Li J, Wang S, Fontana F, Tapeinos C, Shahbazi M, Han H, Santos HA. Nanoparticles-based phototherapy systems for cancer treatment: Current status and clinical potential. Bioactive Materials 2023;23:471-507. [DOI: 10.1016/j.bioactmat.2022.11.013] [Reference Citation Analysis]
2 Zhou Z, Liu Y, Song W, Jiang X, Deng Z, Xiong W, Shen J. Metabolic reprogramming mediated PD-L1 depression and hypoxia reversion to reactivate tumor therapy. J Control Release 2022;352:793-812. [PMID: 36343761 DOI: 10.1016/j.jconrel.2022.11.004] [Reference Citation Analysis]
3 Zhang Y, Hu H, Deng X, Song Q, Xing X, Liu W, Zhang Y. Cascade-Enhanced Catalytic Nanocomposite with Glutathione Depletion and Respiration Inhibition for Effective Starving-Chemodynamic Therapy Against Hypoxic Tumor. IJN 2022;Volume 17:5491-5510. [DOI: 10.2147/ijn.s382750] [Reference Citation Analysis]
4 Conceição IMCAD, Luscher-dias T, Queiroz LR, de Melo AGB, Machado CR, Gomes KB, Souza RP, Luizon MR, Franco GR. Metformin Treatment Modulates Long Non-Coding RNA Isoforms Expression in Human Cells. ncRNA 2022;8:68. [DOI: 10.3390/ncrna8050068] [Reference Citation Analysis]
5 Lu SB, Wei L, He W, Bi ZY, Qian Y, Wang J, Lei H, Li K. Recent Advances in the Enzyme-Activatable Organic Fluorescent Probes for Tumor Imaging and Therapy. ChemistryOpen 2022;11:e202200137. [PMID: 36200519 DOI: 10.1002/open.202200137] [Reference Citation Analysis]
6 Wu P, Han J, Gong Y, Liu C, Yu H, Xie N. Nanoparticle-Based Drug Delivery Systems Targeting Tumor Microenvironment for Cancer Immunotherapy Resistance: Current Advances and Applications. Pharmaceutics 2022;14:1990. [DOI: 10.3390/pharmaceutics14101990] [Reference Citation Analysis]
7 Zhang F, Xin C, Dai Z, Hu H, An Q, Wang F, Hu Z, Sun Y, Tian L, Zheng X. Oncocyte Membrane-Camouflaged Multi-Stimuli-Responsive Nanohybrids for Synergistic Amplification of Tumor Oxidative Stresses and Photothermal Enhanced Cancer Therapy. ACS Appl Mater Interfaces 2022. [PMID: 36052606 DOI: 10.1021/acsami.2c11200] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Fan Y, Cheng H, Liu Y, Liu S, Lowe S, Li Y, Bentley R, King B, Tuason JPW, Zhou Q, Sun C, Zhang H. Metformin anticancer: Reverses tumor hypoxia induced by bevacizumab and reduces the expression of cancer stem cell markers CD44/CD117 in human ovarian cancer SKOV3 cells. Front Pharmacol 2022;13:955984. [DOI: 10.3389/fphar.2022.955984] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Raju GSR, Pavitra E, Varaprasad GL, Bandaru SS, Nagaraju GP, Farran B, Huh YS, Han YK. Nanoparticles mediated tumor microenvironment modulation: current advances and applications. J Nanobiotechnology 2022;20:274. [PMID: 35701781 DOI: 10.1186/s12951-022-01476-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Hong L, Li J, Luo Y, Guo T, Zhang C, Ou S, Long Y, Hu Z. Recent Advances in Strategies for Addressing Hypoxia in Tumor Photodynamic Therapy. Biomolecules 2022;12:81. [DOI: 10.3390/biom12010081] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]